A new study published in the journal Neuron provides evidence that biological sex differences in brain function and hormone ...

New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa ...

Duke scientists may have discovered a game-changing painkiller. SBI-810 is a new non-opioid drug that offers potent pain ...

Dopamine, a small molecule derived from the amino acid tyrosine, plays a significant role in regulating multiple essential ...

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of ...

How CONOCB2 by GDR Labs Combines Conolidine, PEA, and SubNano Delivery to Support Natural, Non-Addictive Comfort BERKELEY, CA ...

Use of the investigational non-opioid analgesic resiniferatoxin appeared to improve pain control in patients with advanced ...

The deal prepares for a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from ...

Chronic pain affects more than 50 million Americans and remains one of the most difficult conditions to treat safely and effectively. While opioids have lo | Drug Discovery And Development ...

Duke University researchers have created SBI-810, an experimental compound that provides pain relief by selectively ...